-
Monday, March 26, 2012 - 5:53am
In-Depth Look at Opko Health's Portfolio and Prospects
OVERVIEW Opko Health (NYSE: OPK) is a mid-cap pharmaceutical stock with several corporate growth strategies: clinical drugs, medical devices, and strategic acquisitions. Of particular interest to many investors is its CEO's systematic buyback of common stock in the open market, totaling over $23...
Read More >> -
A Peek Into The Market Before The Trading Starts
Thursday, February 16, 2012 - 8:26am
Pre-open movers US stock futures are lower this morning, ahead of jobless claims data. Futures for the Dow Jones Industrial Average dropped 33 points to 12,730.00 and S&P 500 index futures fell 4.70 points to 1,337.50. Nasdaq 100 futures declined 3.25 points to 2,554.25. A Peek Into Global...
Read More >> -
Jefferies Reiterates Urban Outfitters Underperform, $19 PT
Monday, September 19, 2011 - 3:57pmJefferies reiterated its Urban Outfitters (NASDAQ: URBN) Underperform rating and $19 price target in a research report published today. In the report, Jefferies states, "We remain cautious around URBN shares as growth slows, returns erode and trends are not expected to snap back anytime soon. With...
Read More >> -
Jefferies Comments on Wynn Resorts
Tuesday, September 13, 2011 - 9:37amJefferies provided color on Wynn Resorts (NASDAQ: WYNN) in a research report published today. Jefferies has previously given Wynn Resorts a Buy rating. In the report, Jefferies states, "Wynn Macau has reached an agreement with the Macau Government for its Cotai Land Concession Contract. We see...
Read More >> -
Jefferies Comments on Forest Labs
Monday, August 1, 2011 - 3:45pmJefferies provided color on Forest Labs (NYSE: FRX) in a research report published today. Jefferies has previously given Forest Labs a Buy rating and $46 price target. In the report, Jefferies states, "We think most people have missed the fact that in its SEC filing on Friday and its letter to...
Read More >> -
Jefferies Maintains Magnum Hunter Buy
Thursday, July 14, 2011 - 2:29pmJefferies maintained its Magnum Hunter (NYSE: MHR) Buy rating in a research report published today. Jefferies has previously given Magnum Hunter an $11 price target. In the report, Jefferies states, "Mid-year reserve growth shows transformative nature of acquisitions. Organic growth tracking below...
Read More >> -
Jefferies Keeps Buy Rating on Lear Corp.
Monday, May 2, 2011 - 9:48amJefferies & Company kept its Buy rating on Lear Corp. (LEA) Friday after the company reported earnings. Jefferies states,"LEA upsided 1Q consensus by a resounding 28%. At 3.7x forward EBITDA, we feel the shares are simply too cheap to ignore. Reiterate Buy rating." Shares of Lear Corp. (LEA)...
Read More >> -
Jefferies Maintains Hold Rating and PT of $9 on shares of Morgans Hotel Group
Monday, May 2, 2011 - 9:41amJefferies & Compnay maintained its Hold rating and Price Target of $9 on shares of Morgans Hotel Group(MHGC) Jefferies states,"We believe the execution of an asset lighter strategy with the recent sale of three owned hotels and new management contracts clearly improve the leverage profile and...
Read More >> -
Jefferies Maintains its Hold Position and $80 PT on McDonald's
Monday, May 2, 2011 - 9:32amJefferies & Company maintained its Hold Position and Price Target of $80 on shares of McDonalds(MCD). Jefferies reported,"We recently spent time with investors at MCD headquarters, meeting with CFO Pete Bensen & APMEA CFO Dave Garland. We came away with increased confidence in the US...
Read More >> -
Jefferies Maintains Hold Rating on Brightpoint Inc.
Monday, May 2, 2011 - 9:25amJefferies & Company has maintained its Hold rating on Brightpoint Inc. (CELL). Jefferies reports,"We expected strong revenues but margin pressures. The Touchstone acq and a mix shift from EMEA to Asia pushed GM lower but ASPs higher for both Logistics and Distribution. Overall, results and...
Read More >>
